ISRG - Intuitive Surgical, Inc.
NEXT EARNINGS:
Apr 28, 2026
EPS Est: $2.08
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$638.75
DETAILS
HIGH:
$750.00
LOW:
$550.00
MEDIAN:
$635.00
CONSENSUS:
$638.75
UPSIDE:
29.30%
Market Cap:
175.44B
Volume:
1,401,152
Avg Volume:
1,865,776
52 Week Range:
425-603.88
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
1.66
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
15,638
IPO Date:
2000-06-16
EPS (TTM):
8.00
P/E Ratio:
70.78
Revenue (TTM):
10.06B
Total Assets:
20.63B
Total Debt:
302.80M
Cash & Equiv:
3.37B
Rev Growth (5Y):
18.2%
EPS Growth (5Y):
21.5%
FCF Growth (5Y):
16.9%
ROCE:
15.8%
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-22 | $2.53 | $2.27 | +11.5% | $2.9B | $2.8B | +3.7% |
| 2025-10-21 | $2.40 | $1.99 | +20.6% | $2.5B | $2.4B | +4.1% |
| 2025-07-22 | $2.19 | $1.93 | +13.5% | $2.4B | $2.4B | +3.8% |
| 2025-04-22 | $1.81 | $1.74 | +4.0% | $2.3B | $2.2B | +3.1% |
| 2025-01-23 | $2.21 | $1.76 | +25.6% | $2.4B | $2.2B | +7.3% |
| 2024-10-17 | $1.84 | $1.63 | +12.9% | $2.0B | $2.0B | +1.6% |
| 2024-07-18 | $1.78 | $1.54 | +15.6% | $2.0B | $2.0B | +1.9% |
| 2024-04-18 | $1.50 | $1.41 | +6.4% | $1.9B | $1.9B | +1.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.06B | 8.35B | 7.12B | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.13B | 2.70B | 2.38B | 2.13B |
| Net Income | 2.86B | 2.32B | 1.80B | 1.32B | 1.70B | 1.06B | 1.38B | 1.13B | 660.00M | 735.90M | 588.80M | 418.80M |
| EPS | 8.00 | 6.54 | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 | 3.31 | 1.97 | 2.13 | 1.76 | 1.26 |
| Total Assets | 20.63B | 18.84B | 15.44B | 12.97B | 13.55B | 11.17B | 9.73B | 7.85B | 5.76B | 6.49B | 4.91B | 3.96B |
| Total Debt | 302.80M | 146.00M | 0 | 0 | 87.00M | 0 | 76.40M | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 3.37B | 2.03B | 2.75B | 1.58B | 1.29B | 1.62B | 1.17B | 857.90M | 3.85B | 4.84B | 3.35B | 2.50B |
| Operating Cash Flow | 3.03B | 2.42B | 1.81B | 1.49B | 2.09B | 1.48B | 1.60B | 1.17B | 1.14B | 1.04B | 771.90M | 665.10M |
| Free Cash Flow | 2.49B | 1.30B | 749.60M | 958.40M | 1.74B | 1.14B | 1.17B | 982.20M | 953.20M | 989.00M | 690.90M | 559.50M |
| FCF per Share | 6.98 | 3.67 | 2.13 | 2.69 | 4.87 | 3.26 | 3.39 | 2.88 | 2.84 | 2.87 | 2.07 | 1.68 |
| Book Value | 17.82B | 16.43B | 13.31B | 11.04B | 11.95B | 9.76B | 8.28B | 6.68B | 4.73B | 5.78B | 4.32B | 3.38B |
| Cash & ST Investments | 5.93B | 4.01B | 5.22B | 4.12B | 4.23B | 5.17B | 3.22B | 3.06B | 3.85B | 4.84B | 3.35B | 2.50B |
| ROC Equity | 0.16 | 0.14 | 0.14 | 0.12 | 0.14 | 0.11 | 0.17 | 0.17 | 0.14 | 0.13 | 0.14 | 0.12 |